AstraZeneca’s new weight-loss pill, AZD5004, shows promise in early trials with tolerable side effects, advancing to Phase II studies focused on reducing obesity.
AstraZeneca reported on Monday that its experimental weight-loss pill, AZD5004, licensed from China's Eccogene for up to $2 billion, was found safe and tolerable in an early-stage trial.
The study, which included 72 participants who were either healthy or had type 2 diabetes, showed side effects consistent with other GLP-1 drugs, such as nausea and vomiting. Based on these findings, AstraZeneca has advanced AZD5004 to Phase II trials focused on weight reduction in overweight and obese individuals, with completion expected by late 2025.
Unlike injectable treatments from competitors Eli Lilly and Novo Nordisk, AZD5004 is a small molecule pill that can be combined with other medications and taken with or without food, offering potential advantages for patients with additional health conditions.
AstraZeneca also shared early-stage data on other obesity drugs, AZD6234 and AZD9550, which target different hunger-related hormones and will undergo further Phase II testing through 2026.
Meanwhile, Viking Therapeutics released early trial results for its own oral obesity drug, which briefly boosted its stock before a decline.
The Somali Army carried out a targeted airstrike in southern Somalia, killing 15 al-Shabaab militants, the country’s Defence Ministry said on Sunday...
Israel’s cabinet on Sunday approved measures aimed at expanding state oversight of land in the occupied West Bank and facilitating land purchases by...
...
Iran is pursuing a nuclear agreement with the U.S. that delivers economic benefits for both sides, an Iranian diplomat was reported as saying on Sunda...
Azerbaijani President Ilham Aliyev and Serbian President Aleksandar Vučić reaffirmed their countries’ strategic partnership in Belgrade on Sunday ...
A groundbreaking study presented at ASCO reveals that AstraZeneca’s experimental pill camizestrant, when used based on blood test results, can halve the risk of breast cancer progression or death—potentially reshaping treatment for patients with hormone receptor-positive, HER2-negative breast cancer
AstraZeneca, opens new tab said it will spend $2.5 billion on a research and development hub in Beijing, as the drugmaker scrambles to revive business in its second-biggest market after scandals including the arrest of its China president last year.
U.S. Ambassador to NATO Matthew Whitaker said China has the power to bring an end to Russia’s war in Ukraine, arguing that Beijing is enabling Moscow’s military campaign.
American figure skating star Ilia Malinin endured a dramatic collapse in the men’s free skate on Friday night, falling twice and tumbling out of medal contention at the Milan Cortina Winter Olympics as Kazakhstan’s Mikhail Shaidorov surged to a surprise gold medal.
“Respected and feared globally,” U.S. President Donald Trump told troops at Fort Bragg on Friday (13 February), framing America’s renewed strength against to mounting pressure on Iran amid stalled nuclear talks.
Speaking at Munich Security Conference, Ukrainian foreign minister Andrii Sybiha calls for decisive steps ahead of expected Geneva talks
Thousands of fans packed River Plate’s Monumental Stadium in Buenos Aires on Friday for the first of three sold-out concerts by Puerto Rican reggaeton star Bad Bunny, as part of his “Debí Tirar Más Fotos” World Tour.
Measles cases across Europe and Central Asia fell sharply in 2025 compared to the previous year but health officials have warned that the risk of fresh outbreaks remains unless vaccination gaps are urgently addressed.
A Florida university has become a new hotspot in a widening U.S. measles outbreak, with health officials confirming multiple infections and hospitalisations.
The World Health Organization has added the Nipah virus to its list of the world’s top 10 priority diseases, alongside COVID-19 and the Zika virus, warning that its epidemic potential highlights the global risk posed by fast-spreading outbreaks.
Belgian authorities are examining suspected cases of infants falling ill after consuming recalled Nestle baby formula, amid warnings that confirmed infections may be underestimated due to limited testing requirements.
Two Nipah infections involving health workers in India have triggered heightened screening across Southeast Asia as authorities move to prevent the high fatality virus from spreading beyond the country.
You can download the AnewZ application from Play Store and the App Store.
What is your opinion on this topic?
Leave the first comment